Stage IV Pancreatic Cancer


Afinitor Approved for Pancreatic Neuroendocrine Tumors (05-10-2011)

The US Food and Drug Administration has approved Afinitor┬« (everolimus) for the treatment of advanced pancreatic neuroendocrine tumors (PNET). Pancreatic neuroendocrine tumors are a relatively uncommon type of cancer that develops in the hormone-producing... Continue Reading